Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

'Ischemic tolerance' phenomenon found in the brain.

K Kitagawa1, M Matsumoto, M Tagaya

  • 1First Department of Internal Medicine, School of Medicine, Osaka University, Japan.

Brain Research
|September 24, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1.

The Journal of biological chemistry·1992
Same author

[Activity of Enterococcus faecalis (FK-23) preparation as a biological response modifier].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·1992
Same author

A novel DNA-binding motif abuts the zinc finger domain of insect nuclear hormone receptor FTZ-F1 and mouse embryonal long terminal repeat-binding protein.

Molecular and cellular biology·1992
Same author

Chronic spontaneous lumbar spinal epidural hematoma.

Spine·1992
Same author

Affinity cross-linked delta-opioid receptor in NG108-15 cells is low molecular weight (25 kDa) and coupled to GTP-binding proteins.

European journal of pharmacology·1992
Same author

Efficient selection of mu m-mutants from mu m-expressing myeloma cells by treatment with ricin A-conjugated anti-mu antibody.

Somatic cell and molecular genetics·1992
Same journal

IGFBP3 and UBE2C are associated with protein modification pathways and serve as prognostic markers in glioma.

Brain research·2026
Same journal

Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

Brain research·2026
Same journal

Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research·2026
Same journal

Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

Brain research·2026
Same journal

Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

Brain research·2026
Same journal

Emotions, the amygdala, and the right hemisphere.

Brain research·2026
See all related articles

Mild ischemic preconditioning can protect brain cells from lethal ischemic events. Repeated mild ischemic treatments, spaced appropriately, significantly enhance this protective effect, offering a potential new approach for treating ischemic brain damage.

Area of Science:

  • Neuroscience
  • Cerebrovascular Biology
  • Cellular Metabolism

Background:

  • Cerebral ischemia can lead to delayed neuronal death, particularly in the hippocampus.
  • Mild ischemic stress can perturb cellular metabolism and protein synthesis without causing neuronal necrosis.

Purpose of the Study:

  • To investigate if mild ischemic preconditioning confers tolerance to subsequent lethal ischemic stress in vivo.
  • To determine the optimal duration and interval for ischemic preconditioning to induce neuroprotection.

Main Methods:

  • Gerbil model of cerebral ischemia induced by carotid artery occlusion.
  • Mild ischemic treatments (2-min) were administered at varying intervals before a lethal ischemic insult (5-min).
  • Neuronal death in the CA1 hippocampal region was assessed to evaluate neuroprotection.

Related Experiment Videos

Main Results:

  • Single mild ischemic treatments offered only partial protection against delayed neuronal death.
  • Two mild ischemic treatments, with a 1-day interval, administered 2 days prior to the lethal insult, provided complete neuroprotection.
  • Short intervals between mild ischemic treatments did not induce significant protective effects.

Conclusions:

  • Repeated mild ischemic stress, with specific timing and duration, can induce a robust 'ischemic tolerance' phenomenon.
  • This phenomenon suggests a potential therapeutic strategy for mitigating ischemic neuronal damage.
  • Further investigation into the pathophysiology of ischemic tolerance is warranted.